SavePeptidesCompound
Re-checked hourly
All peptides
ImmunityPreclinicalVendors pending
PreclinicalVendors pendingFacts verified · 2026-05-25

Thymulin

Also known as facteur thymique sérique, serum thymic factor · Wikipedia

Thymulin, originally called Facteur Thymique Serique (FTS) or serum thymic factor, is a zinc-bound nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells and characterized historically by the Bach group. It is biologically active only when bound to zinc in an equimolar Zn-FTS complex. Endogenous circulating thymulin declines progressively with thymic involution after puberty. It is studied in immune regulation, T-cell differentiation, neuroendocrine-immune interactions, and inflammation, and is offered in the research-chemical channel for immune balance. There are no completed late-phase clinical trials.

best

price

per

mg

vendors

tracked

Preclinical

stage

Vendor data

Coming soon.

Per-vendor pricing and verification tiers populate as the SavePeptides crawler comes online. Until then, browse all approved vendors directly.

Browse all vendors

Mechanism of action

Thymulin is a zinc-dependent nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells; the zinc-bound conformation (Zn-FTS) is essential for biological activity, with one zinc ion per nonapeptide (Cung et al., PubMed 3356698; Reggiani et al.

Thymulin is a zinc-dependent nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells; the zinc-bound conformation (Zn-FTS) is essential for biological activity, with one zinc ion per nonapeptide (Cung et al., PubMed 3356698; Reggiani et al., PubMed 18476235). It promotes T-cell differentiation and maturation, induces expression of T-cell markers (CD3, CD4, CD8), modulates cytokine production (IL-2, IFN-gamma), and shows documented anti-nociceptive and anti-inflammatory effects in animal models, partly via NF-kappaB inhibition and reduced pro-inflammatory cytokine release. Circulating thymulin declines progressively after thymic involution in puberty and is further reduced in zinc-deficient and malnourished states.

Pharmacokinetic properties

Half-life

very short - minutes in plasma; activity dependent on continuous zinc availability

Routes

subcutaneous · intramuscular · intranasal

Bioavailability

Must be co-administered (or endogenously co-available) with zinc to be active. Not orally bioavailable. Several gene-therapy delivery approaches studied preclinically.

Amino-acid sequence

Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn

Use & research dosing

No human regulatory dose is established. Self-experimentation protocols in the research-chemical channel commonly report 100-500 mcg subcutaneously daily in short cycles, typically with zinc co-supplementation given the strict zinc-dependence of biological activity. Most published work is preclinical rodent at microgram per kilogram doses. Without zinc co-availability the molecule is effectively inactive, so any protocol that omits zinc should be considered incomplete. Research framing only.

Research-use framing only. SavePeptides sells nothing for human consumption. Doses above reflect reported research / self-experimentation ranges, not clinical recommendations.

Editorial perspective

Distinct from thymopoietin and the thymosin family. The zinc dependence is mechanistically central - biological activity requires the Zn-bound conformation, so co-availability of zinc matters for both endogenous activity (declines with zinc deficiency) and for any exogenous research protocol. Most evidence is preclinical or small immunology / endocrinology studies from the original Bach group and successors; no late-phase clinical trials have been completed.

— SavePeptides editorial desk · last updated 2026-05-25

Cautions & contraindications

Before researching this compound, note:

  • Biologically inactive in zinc-deficient states - zinc co-availability is essential
  • Limited human clinical experience outside small immunology studies
  • Not approved in US, EU, or UK
  • Caution in autoimmune disease given T-cell modulation
  • Long-term safety in humans undefined
  • Vendor sterility, identity, and purity highly variable
  • Pregnancy and lactation - safety data absent
  • Short plasma half-life makes effective dosing schedules uncertain

Research foundation

The papers behind the page.

  1. [01]https://pubmed.ncbi.nlm.nih.gov/18476235/
  2. [02]https://pubmed.ncbi.nlm.nih.gov/2657247/

Facts verified

2026-05-25

Confidence

low

What this means

  • no late-phase clinical trials
  • biologically inactive without zinc cofactor
  • historical research base (1970s-1990s); limited modern development

How we check →

Vendor data coming soon

All vendors

001 — Independent

We don't list what we wouldn't research.

SavePeptides lists vendors after an initial review and distinguishes verified vendors where additional checks have been completed. We may earn commissions from referral links, and sponsored placements will be clearly disclosed.

002 — Vendor-funded

Free to browse. Supported by referrals.

SavePeptides is free for buyers. We may earn a commission when you order through our links, but we do not lock deals behind a paywall, require an email to view codes, or inflate comparison prices.

003 — Research use

Research-use disclaimer.

SavePeptides surfaces vendor, pricing, and coupon information for research compounds. These products are not intended, approved, or recommended for human consumption. Our content is informational only and does not constitute medical advice.